Literature DB >> 1374744

Quantitative color Doppler imaging in untreated and irradiated choroidal melanoma.

P G Wolff-Kormann1, B A Kormann, K G Riedel, G C Hasenfratz, F H Stefani, F A Spengel, O E Lund.   

Abstract

Histological data indicate the importance of tumor vascularization as a determinant of the biological behavior and the response to radiotherapy in choroidal melanoma. Duplex ultrasound and color Doppler imaging, the combination of B-mode ultrasound and pulse-waved Doppler analysis, were used to measure quantitatively neovascular blood flow in 31 patients with choroidal melanoma. Follow-up studies (20 patients) were performed to investigate the change of tumor blood flow in choroidal melanomas after radiotherapy. Blood flow was detected in 30 out of 31 melanomas (size 3.1-17.8 mm) within the tumor and at the tumor base with a mean peak systolic frequency of 1.0 kHz (range 0.3-2.7 kHz), a mean end diastolic frequency of 0.3 kHz (range 0.1-1.0 kHz), and a mean frequency of 0.7 kHz (range 0.2-1.3 kHz). Two and six months after 106Ru/106Rh beta-ray application, 19 patients showed a significant decrease in peak systolic frequency. This occurred with and in advance of the decrease in the tumor size. In one patient, a rising maximum systolic frequency after radiotherapy marked a recurrent tumor growth. Results indicate that the quantitative measurement of tumor blood flow by duplex ultrasound and color Doppler imaging may be a new diagnostic modality for monitoring the effectiveness of radiotherapy in choroidal melanoma.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1374744

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  8 in total

1.  Ocular arterial blood flow of choroidal melanoma eyes before and after stereotactic radiotherapy using Leksell gamma knife: 2 year follow up.

Authors:  P V Vécsei; K Kircher; G Nagel; S Toma-Bstaendig; I Ruhswurm; M Georgopoulos; M Zehetmayer
Journal:  Br J Ophthalmol       Date:  1999-12       Impact factor: 4.638

2.  Vascular perfusion of choroidal melanoma by 3.0 tesla magnetic resonance imaging.

Authors:  Bruce M Buerk; Jose S Pulido; Ignacio Chiong; Robert Folberg; Deepak P Edward; Mark T Duffy; Keith R Thulborn
Journal:  Trans Am Ophthalmol Soc       Date:  2004

3.  Correlation of histological tumor vascularization and Doppler sonography in patients with malignant melanoma of the choroid.

Authors:  T Damms; H Schäfer; R Guthoff; P Winkler; R Winter
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1995-05       Impact factor: 3.117

4.  Hemodynamic parameters in blood vessels in choroidal melanoma xenografts and rat choroid.

Authors:  Rod D Braun; Asad Abbas; S Omar Bukhari; Willie Wilson
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-09       Impact factor: 4.799

Review 5.  Is observation really appropriate for small choroidal melanomas.

Authors:  J J Augsburger
Journal:  Trans Am Ophthalmol Soc       Date:  1993

6.  A comparison of colour Doppler imaging of orbital vessels and other methods of blood flow assessment.

Authors:  T H Williamson; G M Baxter; A Pyott; W Wykes; G N Dutton
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1995-02       Impact factor: 3.117

7.  Ultrahigh field magnetic resonance and colour Doppler real-time fusion imaging of the orbit--a hybrid tool for assessment of choroidal melanoma.

Authors:  Uwe Walter; Thoralf Niendorf; Andreas Graessl; Jan Rieger; Paul-Christian Krüger; Sönke Langner; Rudolf F Guthoff; Oliver Stachs
Journal:  Eur Radiol       Date:  2014-02-12       Impact factor: 5.315

8.  Evaluation of Choroidal Melanoma Vascularization by Color Doppler Flow Imaging: An Option for Follow-Up Tumor Control Assessment after CyberKnife®?

Authors:  Cinja Kaak; Vinodh Kakkassery; Björn O Scheef; Marco Zschoche; Felix Rommel; Guido Hildebrandt; Steffen Emmert; Christian Junghanß; Rudolf F Guthoff; Anselm M Jünemann; Uwe Walter
Journal:  Medicina (Kaunas)       Date:  2021-05-31       Impact factor: 2.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.